Nuveen Asset Management, LLC Edwards Lifesciences Corp Transaction History

Nuveen Asset Management, LLC

$334 Billion
Q2 2024

A detailed history of Nuveen Asset Management, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 3,053,514 shares of EW stock, worth $203 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

3,053,514

Previous 2,579,254 18.39%

Holding current value

$203 Million

Previous $246 Million 14.44%

% of portfolio

0.08%

Previous 0.07%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$84.3 - $94.31 $40 Million - $44.7 Million	474,260 Added 18.39%	3,053,514 $282 Million
Q1 2024 May 13, 2024	SELL	$72.54 - $95.56 $23.6 Million - $31.1 Million	-325,197 Reduced 11.2%	2,579,254 $246 Million
Q4 2023 Feb 14, 2024	SELL	$61.71 - $77.76 $32.7 Million - $41.2 Million	-530,398 Reduced 15.44%	2,904,451 $221 Million
Q3 2023 Nov 14, 2023	SELL	$69.28 - $93.38 $23.1 Million - $31.1 Million	-332,839 Reduced 8.83%	3,434,849 $238 Million
Q2 2023 Aug 14, 2023	SELL	$81.41 - $94.33 $99.9 Million - $116 Million	-1,227,000 Reduced 24.57%	3,767,688 $355 Million
Q1 2023 May 15, 2023	SELL	$74.26 - $84.51 $31.5 Million - $35.9 Million	-424,788 Reduced 7.84%	4,994,688 $413 Million
Q4 2022 Feb 14, 2023	SELL	$68.3 - $87.44 $9.68 Million - $12.4 Million	-141,672 Reduced 2.55%	5,419,476 $404 Million
Q3 2022 Nov 14, 2022	SELL	$82.37 - $107.29 $86.4 Million - $113 Million	-1,048,938 Reduced 15.87%	5,561,148 $460 Million
Q2 2022 Aug 15, 2022	BUY	$86.5 - $128.27 $39.6 Million - $58.8 Million	458,309 Added 7.45%	6,610,086 $629 Million
Q1 2022 May 16, 2022	BUY	$101.96 - $128.34 $179 Million - $225 Million	1,750,747 Added 39.78%	6,151,777 $686 Million
Q4 2021 Feb 14, 2022	BUY	$106.37 - $130.68 $163 Million - $200 Million	1,533,795 Added 53.49%	4,401,030 $570 Million
Q3 2021 Nov 12, 2021	SELL	$102.91 - $122.75 $37.4 Million - $44.6 Million	-363,021 Reduced 11.24%	2,867,235 $325 Million
Q2 2021 Aug 16, 2021	SELL	$83.84 - $104.76 $10.2 Million - $12.8 Million	-121,771 Reduced 3.63%	3,230,256 $335 Million
Q1 2021 May 17, 2021	SELL	$78.68 - $90.67 $98.9 Million - $114 Million	-1,256,615 Reduced 27.27%	3,352,027 $280 Million
Q4 2020 May 17, 2021	SELL	$71.69 - $91.23 $1.75 Million - $2.23 Million	-24,392 Reduced 0.53%	4,608,642 $420 Million
Q4 2020 Feb 16, 2021	BUY	$71.69 - $91.23 $27 Million - $34.3 Million	376,166 Added 8.84%	4,633,034 $423 Million
Q3 2020 Nov 16, 2020	SELL	$67.19 - $87.44 $51.5 Million - $67.1 Million	-766,973 Reduced 15.27%	4,256,868 $340 Million
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $168 Million - $225 Million	2,920,269 Added 138.82%	5,023,841 $347 Million
Q1 2020 May 14, 2020	SELL	$52.41 - $81.0 $41.2 Million - $63.7 Million	-786,683 Reduced 27.22%	2,103,572 $132 Million
Q4 2019 Feb 14, 2020	SELL	$71.7 - $82.09 $61.5 Million - $70.4 Million	-858,013 Reduced 22.89%	2,890,255 $674 Million
Q3 2019 Nov 14, 2019	SELL	$61.55 - $75.43 $12.5 Million - $15.3 Million	-203,300 Reduced 5.14%	3,748,268 $824 Million
Q2 2019 Aug 15, 2019	BUY	$55.74 - $64.41 $218 Million - $251 Million	3,904,405 Added 8278.53%	3,951,568 $730 Million
Q1 2019 May 14, 2019	SELL	$47.89 - $64.05 $2.25 Million - $3 Million	-46,897 Reduced 49.86%	47,163 $9.02 Million
Q4 2018 Feb 14, 2019	SELL	$46.41 - $56.94 $804,702 - $987,282	-17,339 Reduced 15.56%	94,060 $14.4 Million
Q3 2018 Nov 13, 2018	BUY	$45.7 - $58.03 $982,001 - $1.25 Million	21,488 Added 23.9%	111,399 $19.4 Million
Q2 2018 Aug 14, 2018	BUY	$42.45 - $51.3 $3.58 Million - $4.33 Million	84,448 Added 1545.82%	89,911 $13.1 Million
Q1 2018 May 14, 2018	SELL	$37.19 - $47.45 $3,867 - $4,934	-104 Reduced 1.87%	5,463 $762,000
Q4 2017 Feb 14, 2018	BUY	$33.79 - $39.39 $74,000 - $86,264	2,190 Added 64.85%	5,567 $0
Q3 2017 Nov 14, 2017	BUY	$36.29 - $38.83 $122,551 - $131,128	3,377	3,377 $369,000

Others Institutions Holding EW

# of Institutions

1,417

Shares Held

470M

Call Options Held

2.44M

Put Options Held

2.65M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.2B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Edwards Lifesciences Corp Transaction History